Skip navigation

February 15, 2017
King of Prussia, PA
At Ruth’s Chris Steak House

12:00

Networking Luncheon

1:00

Round Robin Innovation Presentations

The industry is moving further into developing creative new technologies to gather accurate and usable data from real-world evidence, including electronic health records and wearable sensors. In each of these 20-minute presentations, industry thought leaders present their research and initial results of new RWE and mHealth initiatives that aim to improve outcomes.

I. Tufts CSDD Research on Real World Evidence and mHealth in Clinical Research

Presenting Key Takeaways From: A Study Among Key Stakeholders on the Use of Real World Data and Evidence in Clinical Research Evaluate the Value and Return of mHealth Technologies

Mary Jo Lamberti, PhD
Senior Research Fellow
Tufts Center for the
Study of Drug Development

II. Multiple Sclerosis Performance Test (MSPT) — Using Technology to Collect Standardized, Reliable & Clinically Meaningful Patient Data

Fernando Venegas, MBA, PMP
Associate Director, Program Leadership & Management, Value Based Medicine
Biogen

III. mHealth Industry Survey — Findings and Analysis

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

2:00

Life Science Luminaries Panel Discussion

Our esteemed thought leaders join together to discuss how their research adds value and elevates cutting-edge tactics in clinical innovation. Engagement and questions from the audience are welcome.

Stella Stergiopoulos
Research Fellow
Tufts Center for the
Study of Drug Development

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

3:30

Networking and Refreshment Break

4:00

The Future of Clinical Technology — What Lies Ahead?

James Streeter, Global Vice President of Life Sciences Product Strategy at Oracle, will examine how the massive increase in volume, complexity, and velocity of data generated from incorporating realworld evidence and mHealth in clinical trials is forcing companies to adopt advanced technologies including:

“Big data” clouds to manage both structured and unstructured data, rapidly and securely Machine learning to automate the processing of petabytes of data without diminishing accuracy Sophisticated analytics based on machine learning and artificial intelligence to help researchers focus on key areas instead of “noise”

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

4:30

Industry Case Studies —
Transforming Clinical Development with Innovative Clinical Technology

Discover how leading pharmaceutical manufacturers are increasing innovation and collaboration while reducing clinical development cost, time, and risk by adopting innovative cloud solutions.

5:00

Closing Remarks

 

February 16, 2017
Mendham, NJ
At Black Horse Tavern

12:00

Networking Luncheon

1:00

Round Robin Innovation Presentations

The industry is moving further into developing creative new technologies to gather accurate and usable data from real-world evidence, including electronic health records and wearable sensors. In each of these 20-minute presentations, industry thought leaders present their research and initial results of new RWE and mHealth initiatives that aim to improve outcomes.

I. Tufts CSDD Research on Real World Evidence and mHealth in Clinical Research

Presenting Key Takeaways From: A Study Among Key Stakeholders on the Use of Real World Data and Evidence in Clinical Research Evaluate the Value and Return of mHealth Technologies

Stella Stergiopoulos
Research Fellow
Tufts Center for the
Study of Drug Development

II. Multiple Sclerosis Performance Test (MSPT) — Using Technology to Collect Standardized, Reliable & Clinically Meaningful Patient Data

Fernando Venegas, MBA, PMP
Associate Director, Program Leadership & Management, Value Based Medicine
Biogen

III. mHealth Industry Survey — Findings and Analysis

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

2:00

Life Science Luminaries Panel Discussion

Our esteemed thought leaders join together to discuss how their research adds value and elevates cutting-edge tactics in clinical innovation. Engagement and questions from the audience are welcome.

Stella Stergiopoulos
Research Fellow
Tufts Center for the
Study of Drug Development

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

3:30

Networking and Refreshment Break

4:00

The Future of Clinical Technology — What Lies Ahead?

James Streeter, Global Vice President of Life Sciences Product Strategy at Oracle, will examine how the massive increase in volume, complexity, and velocity of data generated from incorporating realworld evidence and mHealth in clinical trials is forcing companies to adopt advanced technologies including:

“Big data” clouds to manage both structured and unstructured data, rapidly and securely Machine learning to automate the processing of petabytes of data without diminishing accuracy Sophisticated analytics based on machine learning and artificial intelligence to help researchers focus on key areas instead of “noise”

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

4:30

Industry Case Studies —
Transforming Clinical Development with Innovative Clinical Technology

Discover how leading pharmaceutical manufacturers are increasing innovation and collaboration while reducing clinical development cost, time, and risk by adopting innovative cloud solutions.

5:00

Closing Remarks

Want more agenda details? Download the brochure.

February 15, 2017
King of Prussia, PA
At Ruth’s Chris Steak House

12:00

Networking Luncheon

1:00

Round Robin Innovation Presentations

The industry is moving further into developing creative new technologies to gather accurate and usable data from real-world evidence, including electronic health records and wearable sensors. In each of these 20-minute presentations, industry thought leaders present their research and initial results of new RWE and mHealth initiatives that aim to improve outcomes.

I. Tufts CSDD Research on Real World Evidence and mHealth in Clinical Research

Presenting Key Takeaways From: A Study Among Key Stakeholders on the Use of Real World Data and Evidence in Clinical Research Evaluate the Value and Return of mHealth Technologies

Mary Jo Lamberti, PhD
Senior Research Fellow
Tufts Center for the
Study of Drug Development

II. Multiple Sclerosis Performance Test (MSPT) — Using Technology to Collect Standardized, Reliable & Clinically Meaningful Patient Data

Fernando Venegas, MBA, PMP
Associate Director, Program Leadership & Management, Value Based Medicine
Biogen

III. mHealth Industry Survey — Findings and Analysis

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

2:00

Life Science Luminaries Panel Discussion

Our esteemed thought leaders join together to discuss how their research adds value and elevates cutting-edge tactics in clinical innovation. Engagement and questions from the audience are welcome.

Stella Stergiopoulos
Research Fellow
Tufts Center for the
Study of Drug Development

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

3:30

Networking and Refreshment Break

4:00

The Future of Clinical Technology — What Lies Ahead?

James Streeter, Global Vice President of Life Sciences Product Strategy at Oracle, will examine how the massive increase in volume, complexity, and velocity of data generated from incorporating realworld evidence and mHealth in clinical trials is forcing companies to adopt advanced technologies including:

“Big data” clouds to manage both structured and unstructured data, rapidly and securely Machine learning to automate the processing of petabytes of data without diminishing accuracy Sophisticated analytics based on machine learning and artificial intelligence to help researchers focus on key areas instead of “noise”

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

4:30

Industry Case Studies —
Transforming Clinical Development with Innovative Clinical Technology

Discover how leading pharmaceutical manufacturers are increasing innovation and collaboration while reducing clinical development cost, time, and risk by adopting innovative cloud solutions.

5:00

Closing Remarks

 

February 16, 2017
Mendham, NJ
At Black Horse Tavern

12:00

Networking Luncheon

1:00

Round Robin Innovation Presentations

The industry is moving further into developing creative new technologies to gather accurate and usable data from real-world evidence, including electronic health records and wearable sensors. In each of these 20-minute presentations, industry thought leaders present their research and initial results of new RWE and mHealth initiatives that aim to improve outcomes.

I. Tufts CSDD Research on Real World Evidence and mHealth in Clinical Research

Presenting Key Takeaways From: A Study Among Key Stakeholders on the Use of Real World Data and Evidence in Clinical Research Evaluate the Value and Return of mHealth Technologies

Stella Stergiopoulos
Research Fellow
Tufts Center for the
Study of Drug Development

II. Multiple Sclerosis Performance Test (MSPT) — Using Technology to Collect Standardized, Reliable & Clinically Meaningful Patient Data

Fernando Venegas, MBA, PMP
Associate Director, Program Leadership & Management, Value Based Medicine
Biogen

III. mHealth Industry Survey — Findings and Analysis

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

2:00

Life Science Luminaries Panel Discussion

Our esteemed thought leaders join together to discuss how their research adds value and elevates cutting-edge tactics in clinical innovation. Engagement and questions from the audience are welcome.

Stella Stergiopoulos
Research Fellow
Tufts Center for the
Study of Drug Development

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

3:30

Networking and Refreshment Break

4:00

The Future of Clinical Technology — What Lies Ahead?

James Streeter, Global Vice President of Life Sciences Product Strategy at Oracle, will examine how the massive increase in volume, complexity, and velocity of data generated from incorporating realworld evidence and mHealth in clinical trials is forcing companies to adopt advanced technologies including:

“Big data” clouds to manage both structured and unstructured data, rapidly and securely Machine learning to automate the processing of petabytes of data without diminishing accuracy Sophisticated analytics based on machine learning and artificial intelligence to help researchers focus on key areas instead of “noise”

James Streeter
Global Vice President,
Life Sciences Product Strategy
Oracle

4:30

Industry Case Studies —
Transforming Clinical Development with Innovative Clinical Technology

Discover how leading pharmaceutical manufacturers are increasing innovation and collaboration while reducing clinical development cost, time, and risk by adopting innovative cloud solutions.

5:00

Closing Remarks